Naveen Pemmaraju welcomes Charan Thej Reddy Vegivinti to MD Anderson Cancer Center team
Naveen Pemmaraju’s shared a post on X:
“Welcome to MD Anderson Cancer Center Charan Thej Reddy Vegivinti. So happy to meet up with you and all best wishes as you start your journey with us!”
Charan Thej Reddy Vegivinti, Hematology Oncology fellow at MD Anderson Cancer Center, reshared a post by Naveen Pemmaraju on X, adding:
“Thank you so much Naveen Pemmaraju. Excited to be part of MD Anderson Cancer Center family and the the incredible Hematology Oncology team.”
Source: Naveen Pemmaraju/X and Charan Thej Reddy Vegivinti/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.